BioCentury
ARTICLE | Company News

Atrix deal

January 10, 1994 8:00 AM UTC

Syntex is studying LH-RH antagonists to treat prostatic cancer, uterine fibroids, endometriosis and related diseases. The agreement comes at the end of a period of preliminary research to determine wh...